CoChat

Estimating the direct and indirect costs for community-dwelling patients with schizophrenia: Schizophrenia-related costs for community-dwellers

Desai, Pooja R., Lawson, Kenneth A., Barner, Jamie C., Rascati, Karen L. · 2013 · Journal of Pharmaceutical Health Services Research
Cited by 99

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

To estimate the schizophrenia-related direct and indirect costs for community-dwelling Americans sampled in the Medical Expenditure Panel Survey (MEPS) from the societal perspective. Patients diagnosed with a schizophrenic disorder (International Classification of Disease 9th Revision (ICD-9) code 295) or other non-organic psychoses (ICD-9 code 298) between 1 January 2005 and 31 December 2008 were identified from the MEPS database. The following categories were included in calculating the schizophrenia-related direct medical costs: inpatient hospitalizations, prescription medications and hospital outpatient, emergency department, physician office, and home healthcare visits. The indirect costs were calculated using the human capital approach and included lost productivity due to missed work, reduced employment, premature death and caregivers’ costs. To account for the complex multistage sampling design of the MEPS, all statistical analyses were conducted using the survey procedure of SAS version 9.2. We identified 348 patients who represent 3.03 million community-dwelling schizophrenia patients in the USA between 2005 and 2008. The estimated direct cost from 2005–2008 was US$17.1 billion, or approximately US$4 billion per year, with a mean annual cost per patient of US$5984. The indirect costs over the same 4-year period amounted to US$74.74 billion, or approximately US$18.68 billion per year, with a mean annual cost per patient of US$24 664. Assuming equal utilization each year, the annual total costs were approximately US$23 billion. The financial burden imposed by schizophrenia was disproportionately high. The mean annual prevalence of schizophrenia in the community was about 0.25% while the annual costs were about US$23 billion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jphs.12027

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 99

Metadata

Authors
Desai, P. R., Lawson, K. A., Barner, J. C., & Rascati, K. L.
Venue
Journal of Pharmaceutical Health Services Research
Published
2013-07-16
Volume
4
Issue
4
Pages
187-194
ISSN
1759-8885 (ISSN-L)
OpenAlex
W1838285883
Cited by
99
References
7
FWCI
1.70
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estimating the direct and indirect costs for community-dwelling patients with schizophrenia: Schizophrenia-related costs for community-dwellers. https://app.cochat.ai/papers/10.1111/jphs.12027
The paper
Desai, P. R., Lawson, K. A., Barner, J. C., & Rascati, K. L. (2013). Estimating the direct and indirect costs for community-dwelling patients with schizophrenia: Schizophrenia-related costs for community-dwellers. Journal of Pharmaceutical Health Services Research. https://doi.org/10.1111/jphs.12027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.